The Potential Anti-Tumor Extract Of Ocimum Basilicum Lamiaceae Towards Colorectal Cancer Via The Angiogenesis Mechanistic Pathway

Angiogenesis is a process of new blood vessel development which can be triggered by inflammation. Both processes play crucial role in colorectal cancer. Natural products that have high level of antioxidants are known to have anti-inflammatory and anti-angiogenic activity and hence could be useful to treat colon cancer. In this work present here, methanolic extracts of 19 plant species of lamiaceae family found in Saudi Arabia were screened for their anti-angiogenic activity to ascertain their potency towards colon cancer. Only six extracts inhibited neovascularization formation by 50% or more, namely Thymbra capitate (Arial part) (97.93±2.63%), Premna resinosa (Stem) (85.03±16.84%), Phlomis viscosa Poir (Arial part) (81.47±22.95%), Salvia samuelssonii (Arial part) (55.69±12.72%), Ocimum basilicum (Leaves) (54.55 ± 4.27%) and Ocimum basilicum (Arial part) (53.99 ± 8.75%). However, methanolic extract of Ocimum basilicum (OB) leaves shown the highest inhibition towards endothelial cells proliferation and migration among other extracts. (OB) leaves were extracted with 70% ethanol (OBL70) at 55 ⁰C, causing a 43% increase in the anti-angiogenic properties compared to methanolic extract. OBL70 was studied in vitro against endothelial cells proliferation, cytotoxicity, migration, invasion and capillary-like structures using MTT, colony formation, scratch, invasion and tube formation assays, respectively

Synthesis and Characterization of Novel Phyto-Mediated Catalyst, and Its Application for a Selective Oxidation of (VAL) into Vanillin under Visible Light

Here, we report an efficient and highly selective oxidation of lignin model substrate using phyto-mediated ZnFe2O4 nanoparticle using Boswellia carterii extract. The nanocatalyst with an average size of 8 nm showed excellent photocatalytic activity of the synthesized carbonyl containing products under visible light irradiation. The catalytic activity and selectivity towards oxidation of vanillyl alcohol to vanillin with selectivity up to 99% at conversion over 98% and turn-over frequency values up to 1600 h−1 were obtained in the presence of H2O2 and base. The cubic spinel nano-ZnFe2O4 catalyst was characterized by powder-XRD, FESEM, HR-TEM and Mössbauer analysis. The demonstrated catalyst was robust and stable under the reaction conditions. Furthermore, it was easy to be separated from the reaction mixture and be reused for subsequent reactions up to 5 times without significant reactivity or selectivity loss

Validated Capillary Zone Electrophoresis Method for Impurity Profiling and Determination of NiII(3-OMe-Salophene)

A capillary zone electrophoresis method was developed for the determination of NiII(3-OMe-salophene), a substance with anticancer activity in vitro. A fused silica capillary (56 cm × 100 µm) was used for this purpose. The method was optimized in terms of parameters affecting the electrophoretic conditions in order to optimize separation efficiency and total time of migration. The analysis was best performed using an operating buffer of 50 mM borate, adjusted to pH 9.3, mixed with acetonitrile (50%, v/v) as organic modifier. Injections were performed hydrodynamically by applying a pressure of 50 mbar for 8 s, and a 30 kV separation voltage was selected at 25 °C. Detection was carried out at 250 nm using diode array detector (DAD). The method allowed the separation of NiII(3-OMe-salophene) from four other structurally related impurities in a total migration time (tm) of 8 min. Peak identification was achieved using the standard reference of individual impurities. The purity of the migrated NiII(3-OMe-salophene) was confirmed by Ultra-violet (UV) scan overlay depending on DAD. The linear ranges for the determination of NiII(3-OMe-salophene) was 400–20,000 ng mL−1 with limit of detection (LOD) of 120 ng mL−1. Acceptable intra-day and inter-day precisions were achieved (%relative standard deviation (RSD) results were less than 0.76% and 0.30%, respectively). The proposed method was assessed for greenness and compared to reported methodologies to prove superiority

Synthesis and Characterization of Novel Phyto-Mediated Catalyst, and Its Application for a Selective Oxidation of (VAL) into Vanillin under Visible Light

Here, we report an efficient and highly selective oxidation of lignin model substrate using phyto-mediated ZnFe2O4 nanoparticle using Boswellia carterii extract. The nanocatalyst with an average size of 8 nm showed excellent photocatalytic activity of the synthesized carbonyl containing products under visible light irradiation. The catalytic activity and selectivity towards oxidation of vanillyl alcohol to vanillin with selectivity up to 99% at conversion over 98% and turn-over frequency values up to 1600 h−1 were obtained in the presence of H2O2 and base. The cubic spinel nano-ZnFe2O4 catalyst was characterized by powder-XRD, FESEM, HR-TEM and Mössbauer analysis. The demonstrated catalyst was robust and stable under the reaction conditions. Furthermore, it was easy to be separated from the reaction mixture and be reused for subsequent reactions up to 5 times without significant reactivity or selectivity loss

Contrast medium administration and image acquisition parameters in renal CT angiography: what radiologists need to know

Over the last decade, exponential advances in computed tomography (CT) technology have resulted in improved spatial and temporal resolution. Faster image acquisition enabled renal CT angiography to become a viable and effective noninvasive alternative in diagnosing renal vascular pathologies. However, with these advances, new challenges in contrast media administration have emerged. Poor synchronization between scanner and contrast media administration have reduced the consistency in image quality with poor spatial and contrast resolution. Comprehensive understanding of contrast media dynamics is essential in the design and implementation of contrast administration and image acquisition protocols. This review includes an overview of the parameters affecting renal artery opacification and current protocol strategies to achieve optimal image quality during renal CT angiography with iodinated contrast media, with current safety issues highlighted

Quantitative analysis of total phenolic and flavonoid compounds in different extracts from ginger plant (Zingiber officinale) and evaluation of their anticancer effect against colorectal cancer cell lines

Objectives: To quantify quercetin, gallic acid, rutin, naringin, and caffeic acid in the rhizome of Zingiber officinale different extracts in seven different solvents (methanol, ethanol, ethyl acetate, water, dichloromethane, chloroform, and n-hexane), for the first time, using HPLC/UV. Also, to study the anticancer activity of Zingiber officinale different extracts by evaluating its in vitro toxicity on HT-29 colorectal cancer cell line. Methods: The fresh and dried rhizomes were extracted using Soxhlet (SOX) and maceration (MAC) methods. Separation of compounds was conducted using HPLC. The cell line used for MTT cell proliferation assay antiproliferative; is HT-29 (HTB-38) colorectal adenocarcinoma. Results: The MTT test indicated that powder ginger extracted by MAC or SOX showed high cytotoxicity activity (IC50<50) against HT-29 cells, except water using SOX, which showed mild cytotoxicity activity. The fresh ginger extracted by MAC using dichloromethane and those extracted by SOX using ethyl acetate showed strong cytotoxicity activity (IC50 <50). Conclusion: The phenolic and flavonoid contents of ginger can vary depending on the different extracts from ginger plant. Also, HPLC results revealed that quercetin was the highest in all extracts

In vitro anti-angiogenic properties of ethanolic crude extract of Vernonia amygdalina

Angiogenesis is the process of generating new blood vessels that deliver tumor cells with oxygen and essential nutrients for growth and metastasis. This study examined the in vitro antiangiogenic properties of the ethanolic crude extract from Vernonia amygdalina (VA) grown in Malaysia. The direct antiangiogenic activity of VA was evaluated on EA.hy926 cells using in vitro assessments: Cell proliferation, colony formation, migration, and cell invasion assays. VA ethanolic crude extract cytotoxic activity was evident in the antiproliferative and colony formation assays. The growth inhibition (IC50) of 50% against EA.hy926 endothelial cells was achieved after 72 h treatment at a concentration of 85.43±3.57 μg/mL. Upon 48 h treatment, colony formation was inhibited completely at 100 μg/mL while 51.94% inhibition was achieved at 50 μg/mL. Moreover, the extract showed 54.72% and 31.99% inhibitory effects against migration of cells when treated for 24 h treatment at two different concentrations, 25 μg/mL and 12.5 μg/mL, respectively. The use of 100 μg/mL VA ethanolic extract inhibited cell invasion by 35.43%, which was lower than that of 57.81% inhibition achieved by the vinblastine as a positive control. All in all, the present work clearly demonstrated the antiangiogenic properties of VA ethanolic extract that may reflect a chemotherapeutic and/or chemoprevention potential for biomedical applications

Twelve-month observational study of children with cancer in 41 countries during the COVID-19 pandemic

Introduction Childhood cancer is a leading cause of death. It is unclear whether the COVID-19 pandemic has impacted childhood cancer mortality. In this study, we aimed to establish all-cause mortality rates for childhood cancers during the COVID-19 pandemic and determine the factors associated with mortality. Methods Prospective cohort study in 109 institutions in 41 countries. Inclusion criteria: children <18 years who were newly diagnosed with or undergoing active treatment for acute lymphoblastic leukaemia, non-Hodgkin's lymphoma, Hodgkin lymphoma, retinoblastoma, Wilms tumour, glioma, osteosarcoma, Ewing sarcoma, rhabdomyosarcoma, medulloblastoma and neuroblastoma. Of 2327 cases, 2118 patients were included in the study. The primary outcome measure was all-cause mortality at 30 days, 90 days and 12 months. Results All-cause mortality was 3.4% (n=71/2084) at 30-day follow-up, 5.7% (n=113/1969) at 90-day follow-up and 13.0% (n=206/1581) at 12-month follow-up. The median time from diagnosis to multidisciplinary team (MDT) plan was longest in low-income countries (7 days, IQR 3-11). Multivariable analysis revealed several factors associated with 12-month mortality, including low-income (OR 6.99 (95% CI 2.49 to 19.68); p<0.001), lower middle income (OR 3.32 (95% CI 1.96 to 5.61); p<0.001) and upper middle income (OR 3.49 (95% CI 2.02 to 6.03); p<0.001) country status and chemotherapy (OR 0.55 (95% CI 0.36 to 0.86); p=0.008) and immunotherapy (OR 0.27 (95% CI 0.08 to 0.91); p=0.035) within 30 days from MDT plan. Multivariable analysis revealed laboratory-confirmed SARS-CoV-2 infection (OR 5.33 (95% CI 1.19 to 23.84); p=0.029) was associated with 30-day mortality. Conclusions Children with cancer are more likely to die within 30 days if infected with SARS-CoV-2. However, timely treatment reduced odds of death. This report provides crucial information to balance the benefits of providing anticancer therapy against the risks of SARS-CoV-2 infection in children with cancer

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

Background: The EMPA KIDNEY trial showed that empagliflozin reduced the risk of the primary composite outcome of kidney disease progression or cardiovascular death in patients with chronic kidney disease mainly through slowing progression. We aimed to assess how effects of empagliflozin might differ by primary kidney disease across its broad population. Methods: EMPA-KIDNEY, a randomised, controlled, phase 3 trial, was conducted at 241 centres in eight countries (Canada, China, Germany, Italy, Japan, Malaysia, the UK, and the USA). Patients were eligible if their estimated glomerular filtration rate (eGFR) was 20 to less than 45 mL/min per 1·73 m2, or 45 to less than 90 mL/min per 1·73 m2 with a urinary albumin-to-creatinine ratio (uACR) of 200 mg/g or higher at screening. They were randomly assigned (1:1) to 10 mg oral empagliflozin once daily or matching placebo. Effects on kidney disease progression (defined as a sustained ≥40% eGFR decline from randomisation, end-stage kidney disease, a sustained eGFR below 10 mL/min per 1·73 m2, or death from kidney failure) were assessed using prespecified Cox models, and eGFR slope analyses used shared parameter models. Subgroup comparisons were performed by including relevant interaction terms in models. EMPA-KIDNEY is registered with ClinicalTrials.gov, NCT03594110. Findings: Between May 15, 2019, and April 16, 2021, 6609 participants were randomly assigned and followed up for a median of 2·0 years (IQR 1·5–2·4). Prespecified subgroupings by primary kidney disease included 2057 (31·1%) participants with diabetic kidney disease, 1669 (25·3%) with glomerular disease, 1445 (21·9%) with hypertensive or renovascular disease, and 1438 (21·8%) with other or unknown causes. Kidney disease progression occurred in 384 (11·6%) of 3304 patients in the empagliflozin group and 504 (15·2%) of 3305 patients in the placebo group (hazard ratio 0·71 [95% CI 0·62–0·81]), with no evidence that the relative effect size varied significantly by primary kidney disease (pheterogeneity=0·62). The between-group difference in chronic eGFR slopes (ie, from 2 months to final follow-up) was 1·37 mL/min per 1·73 m2 per year (95% CI 1·16–1·59), representing a 50% (42–58) reduction in the rate of chronic eGFR decline. This relative effect of empagliflozin on chronic eGFR slope was similar in analyses by different primary kidney diseases, including in explorations by type of glomerular disease and diabetes (p values for heterogeneity all >0·1). Interpretation: In a broad range of patients with chronic kidney disease at risk of progression, including a wide range of non-diabetic causes of chronic kidney disease, empagliflozin reduced risk of kidney disease progression. Relative effect sizes were broadly similar irrespective of the cause of primary kidney disease, suggesting that SGLT2 inhibitors should be part of a standard of care to minimise risk of kidney failure in chronic kidney disease. Funding: Boehringer Ingelheim, Eli Lilly, and UK Medical Research Council

Synthesis, Characterization and Study of the Biological activity of Some Aldimines Derivatives

A number of imines derivatives have been synthesized, they were obtained by condensation of aromatic aldehyde derivatives with primary aromatic amine derivatives. Their structures have been characterised by IR, 1H NMR in addition to the elemental analysis. The biological activity of these imines (which are also known as Schiff bases) were examined against different type of microorganisms and they found to have considerable activity in comparison with the most commonly used antibiotics